PKP1 and breast cancer: At the post-transcriptional level, miR-328a mitigates the oncogenic effects of PKP1 by directly targeting it (Wang et al., 2020), while the lncRNA APPAT acts as a miR-328a sponge to modulate PKP1 expression in breast cancer (Wang et al., 2020).